A Swedish surgery team has successfully implanted a trachea implant colonised with stem cells. The scientists did not require a donor organ, as they had also created an artificial scaffold, which was not the case in previous transplantations.

Researchers at the Fraunhofer Institute of Laser Technology (ILT) in Aachen, Germany, and other Fraunhofer institutes have used a special laser technique to create hybrid biomimetic matrices which can serve as basis for scaffold and implant structures on which cells can grow.

The California Institute for Regenerative Medicine (CIRM) has startet the fifth call with the title "Early Translational III Research Awards". Within the scope of a cooperation project, german researchers can also apply for the CIRM annoncement to receive promotional funding.  However, such researchers can also apply which develope in vitro models.

In an open letter to the British government, a group of renowned doctors and scientists of Great Britain have voiced concerned about the failure of drugs and the continuosly increasing number of drug side effects.

Switzerland: Increase of animal experiments

Wednesday, 06 July 2011 18:39

Last year in Switzerland 761,675 animals were used in experiments. This is an increase of 8 per cent in compare to 2009. For the first time in four years, animal experiments were realised once again for the cosmetic industry.

In 2010, 187,236 laboratory animals were used in Austria. mainly mice. In the year before, 207,738 animals were used.

About the animal protection research award of Rhineland-Palatinate at 30th june 2011

For the third time, the state Rhineland-Palatine has awarded the price for the promotion of research into replacement and supplement to animal experiments. This year the expert jury has voted for the research group´s works of Prof. Dr. Claus-Michael Lehr, Dr. Eva-Maria Collnot and Fransisca Leonard from the University of the Saar, Department Pharmacy, Biopharmacy and Pharmaceutical Technology and from the Helmholtz Institute for Pharmaceutial Research Saarland (HIPS), Department Drug Delivery.

For the third time, the state Rhineland-Palatine has awarded the price for the promotion of research into replacement and supplement to animal experiments. This year the expert jury has voted for the research group´s works of Prof. Dr. Claus-Michael Lehr, Dr. Eva-Maria Collnot and Fransisca Leonhard from the University of the Saar, Department Pharmacy, Biopharmacy and Pharmaceutical Technology. The director of the research group, Prof. Dr. Claus-Michael Lehr, gave an short interview to InVitroJobs in the run-up of the price-giving.

The Reinhart Koselleck Projects funded by the German Research Foundation (DFG) support particularly innovative and – in a positive sense – high-risk projects, thus providing more scope for development.

The European joint venture DETECTIVE under the supervision of Prof. Dr. Jürgen Hescheler has been given methodological support by the ROCHE concern. The development of the xCELLigence-RTCA-cardio system makes it possible to investigate toxicological effects of products and ingredients in human heart cells in long-term toxicity tests.